Clinical correlates of similar pathologies in parkinsonian syndromes

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 499-506

  Song, Yun Ju Christine ^a   Huang, Yue ^a   Halliday, Glenda Margaret ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Atrophy; Clinical features; Multiple system atrophy; Parkinson's disease; Pathological severity; Progressive supranuclear palsy

Indexed keywords

ALPHA SYNUCLEIN; LEVODOPA; TAU PROTEIN;

AGED; AKINESIA; ARTICLE; ATAXIA; AUTONOMIC DYSFUNCTION; BASAL GANGLION; BRAIN ATROPHY; BRAIN DEGENERATION; BRAIN SIZE; CAUDATE NUCLEUS; CELL LOSS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DEMENTIA; DISEASE DURATION; DISEASE SEVERITY; DYSARTHRIA; DYSPHAGIA; FALLING; FEMALE; GAZE PARALYSIS; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; ONSET AGE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PHENOTYPE; PONS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; RIGIDITY; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; TREATMENT RESPONSE; TREMOR;

AGED; AGED, 80 AND OVER; ATROPHY; CELL DEATH; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROFILAMENT PROTEINS; PARKINSONIAN DISORDERS; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 79953288616     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23336     Document Type: Article

References (41)

1. O'Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008; 131 ( Part 5): 1362-1372.
2. Michotte A. Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism. Acta Neurol Belg 2003; 103: 155-158.
3. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
4. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105.
5. Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007; 33: 615-620.
6. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004; 3: 93-103.
7. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1998; 50: 318.
9. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic parkinson's disease and diffuse Lewy body disease. Dementia 1996; 7: 304-313.
10. Halliday GM, Song YJ, Lepar G, et al. Pick bodies in a family with presenilin-1 Alzheimer's disease. Ann Neurol 2005; 57: 139-143.
11. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
12. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007; 130( Part 6): 1566-1576.
13. Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005; 20 ( Suppl 12): S29-S36.
14. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003; 110: 151-169.
15. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050-2055.
16. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006; 21: 989-996.
17. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129( Part 4): 1040-1049.
18. Minnerop M, Specht K, Ruhlmann J, et al. Voxel-based morphometry and voxel-based relaxometry in multiple system atrophy-a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 2007; 36: 1086-1095.
19. von Lewinski F, Werner C, Jorn T, Mohr A, Sixel-Doring F, Trenkwalder C. T2*-weighted MRI in diagnosis of multiple system atrophy. a practical approach for clinicians. J Neurol 2007; 254: 1184-1188.
20. Slowinski J, Imamura A, Uitti RJ, et al. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008; 255: 37-44.
21. Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008; 23: 727-733.
22. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain 1997; 120 ( Part 1): 65-74.
23. Kim YJ, Ichise M, Ballinger JR, et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2002; 17: 303-312.
24. Seppi K, Scherfler C, Donnemiller E, et al. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis. Arch Neurol 2006; 63: 1154-1160.
25. Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2003; 60: 1766-1769.
26. Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005; 64: 675-679.
27. Nicoletti G, Tonon C, Lodi R, et al. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord 2008; 23: 2370-2376.
28. Kishore A, Panikar D, Balakrishnan S, Joseph S, Sarma S. Evidence of functional somatotopy in GPi from results of pallidotomy. Brain 2000; 123 Pt 12: 2491-2500.
29. Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 2008; 70( 16 Part 2): 1403-1410.
30. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009; 132( Part 1): 156-171.
31. Pellecchia MT, Barone P, Mollica C, et al. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord 2009; 24: 689-696.
32. Syrjala P, Luukinen H, Pyhtinen J, Tolonen U. Neurological diseases and accidental falls of the aged. J Neurol 2003; 250: 1063-1069.
33. Salvatore E, Varrone A, Criscuolo C, et al. Nigrostriatal involvement in ataxia with oculomotor apraxia type 1. J Neurol 2008; 255: 45-48.
34. Wullner U, Reimold M, Abele M, et al. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol 2005; 62: 1280-1285.
35. Lasek K, Lencer R, Gaser C, et al. Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17). Brain 2006; 129 ( Part 9): 2341-2352.
36. Loy CT, Sweeney MG, Davis MB, et al. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord 2005; 20: 1521-1523.
37. Salvatore E, Varrone A, Sansone V, et al. Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17. Mov Disord 2006; 21: 872-875.
38. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127 ( Part 12): 2657-2671.
39. Kanazawa M, Shimohata T, Toyoshima Y, et al. Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study. Mov Disord 2009; 24: 1312-1318.
40. Hoshi E, Tremblay L, Feger J, Carras PL, Strick PL. The cerebellum communicates with the basal ganglia. Nat Neurosci 2005; 8: 1491-1493.
41. Russmann H, Vingerhoets F, Ghika J, Maeder P, Bogousslavsky J. Acute infarction limited to the lenticular nucleus: clinical, etiologic, and topographic features. Arch Neurol 2003; 60: 351-355.